Latest Processing News

Page 12 of 1179
Regis Resources maintained FY27 production and cost guidance after September rainfall cut first-quarter output to 83.0koz and pushed AISC to $3,617/oz. Cash and bullion still rose to $1.28 billion, although a large tax payment and dividend have created a significant near-term cash call.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Wia Gold has emerged from a pivotal quarter with a 1.95Moz Probable Ore Reserve, A$229.2 million in cash and a proposed US$360 million debt facility supporting its Kokoseb development plan. Construction preparations are advancing, but lender approval, definitive financing documents and Namibian permits remain crucial hurdles before early works can begin.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Critica’s Jupiter Scoping Study points to a potentially large Western Australian rare earths operation with a modelled pre-tax NPV of A$2.7 billion and after-tax NPV of A$2.0 billion. The headline economics remain preliminary, rely on modelled pricing and tax incentives, and require about A$556 million in pre-production capital that has not yet been secured.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Rox Resources has accelerated underground development and advanced construction at Youanmi, with the processing plant 39% complete and first gold still targeted for mid-2027. The project is now fully permitted and funded facilities have begun drawing, although construction spending and one major contract remain in focus.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Bellevue Gold has kept FY27 production and cost guidance intact despite a slower-than-expected mining contractor ramp-up that reduced September-quarter output to 35,585 ounces. The company also cut forward sales commitments to 57.5koz, increasing its future exposure to spot gold prices while capital spending weighed on free cash flow.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Everest Metals has advanced its Mt Edon rubidium project towards pilot plant development after batch testing delivered recovery of up to 90% and cut leaching water use by 60%. The scale-up remains unfinished, with continuous rotary-kiln trials producing lower and variable recovery of 50% to 60%.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Rua Bioscience has raised approximately NZ$1.0 million through its rights offer, well short of the NZ$2.8 million sought. The medicinal cannabis company says it still needs more working capital to fund inventory for its UK expansion.
Ada Torres
Ada Torres
20 Oct 2026
Emerald Resources delivered a sharp lift in FY26 profit as its Okvau gold mine generated the cash to fund two new developments. The debt-free, unhedged producer is now moving Dingo Range and Memot from permitting and study work towards construction, while warning that key reserves and timing milestones are still ahead.
Maxwell Dee
Maxwell Dee
19 Oct 2026
Sunshine Metals is moving Mt Moss toward a planned mid-2027 first gold pour, but its annual report carries a material uncertainty over going concern as the company faces a $10 million deferred payment and roughly $30 million of development spending. The ASX-listed explorer reported a narrower FY2026 loss and $20.57 million in cash after a year of major capital raisings and project expansion.
Maxwell Dee
Maxwell Dee
19 Oct 2026
Finexia Financial Group subsidiary Shared Beginnings has entered voluntary administration after Finexia decided to stop providing further financial support. The move places seven early learning centres across three jurisdictions under administrator control, while the potential financial impact on Finexia remains uncertain.
Claire Turing
Claire Turing
19 Oct 2026
M Battery Materials has lodged a prospectus for a $15 million to $25 million IPO, taking its proposed acquisition of LE Minerals’ Queensland graphite assets into a more concrete phase. The transaction still requires LE Minerals shareholder approval and successful ASX admission.
Victor Sage
Victor Sage
19 Oct 2026
Ramsay Health Care’s proposed separation of its 52.79% Ramsay Santé stake has reached a key regulatory milestone, with ASIC registering the Demerger Booklet. Shareholders will vote on the transaction on 24 November, but approval remains only one step in a process that could create two separately traded healthcare exposures.
Ada Torres
Ada Torres
19 Oct 2026

Browse the archive

Full archive